U.S. Health System Needs “Innovation Criteria” To Steer Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
Policymakers should attempt to define "innovation criteria" to help guide healthcare resources towards more significant technological advances, Johnson & Johnson Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia